An observational study in Sepsis, Retinal Microcirculation Disorder and Conjunctiva; Disorder, sponsored by Lithuanian University of Health Sciences. Completed at 1 site in Lithuania. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-01-02.
Sponsored by Lithuanian University of Health Sciences · Observational
This study evaluates differences in the ocular microcirculation between septic patients and healthy subjects and the course of ocular microvasculature in survivors and non-survivors over a 24 hours period of time in septic patients
Conjunctival imaging, using IDF video microscope, and retinal imaging, using portable digital fundus camera, as well as systemic hemodynamic measurements, were performed in septic patients at three time points: at baseline, 6 hours and 24 hours. Baseline conjunctival and retinal microcirculatory parameters were compared with healthy controls.
1,894 studies on the registry are indexed under Sepsis; 458 are open to participants now.
This study's enrollment of 76 is below the median of 160 across 929 observational studies indexed under Sepsis.
Browse Sepsis studies →Lithuanian University of Health Sciences is the lead sponsor of 102 studies on the registry; 31 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Adult patients with sepsis or septic shock within the first 24 hours after ICU admission
Exclusion Criteria:
It allows to look at conjunctival microcirculation
It allows to monitor retinal microvasculature
Microvascular flow index in conjunctival small vessels
Differences in MFI in conjunctival small vessels between septic patients and healthy controls and differences between survivors and non-survivors
Time frame: 24 hours
Central retinal arteriolar equivalent of retinal vessels
Differences in central retinal arteriolar equivalent of retinal vessels between septic patients and healthy controls and differences between survivors and non-survivors
Time frame: 24 hours
Plan to share: No
This study is completed, as verified in Dec 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Lithuanian University of Health Sciences